Structural basis for Parkinson's disease-linked LRRK2's binding to microtubules

Area of Science:

• Biochemistry
• Cell Biology
• Neuroscience

Background:

• Leucine-rich repeat kinase 2 (LRRK2) is a key gene implicated in familial Parkinson's disease (PD).
• LRRK2 has been observed to co-localize with microtubules, particularly when associated with PD mutations.
• Understanding LRRK2-microtubule interactions is crucial for elucidating PD pathogenesis.

Purpose of the Study:

• To determine the structural basis of LRRK2's interaction with microtubules.
• To compare the microtubule-binding properties of LRRK2 and its close homolog LRRK1.
• To identify specific residues in LRRK2 responsible for microtubule binding.

Main Methods:

• Cryo-electron microscopy (cryo-EM) to obtain high-resolution structures of LRRK2 and LRRK1.
• Biochemical assays to assess in vitro microtubule binding.
• Cell-based experiments to validate the role of identified residues in microtubule interaction.

Main Results:

• A cryo-EM structure of the catalytic half of LRRK2 bound to microtubules in a closed conformation was determined.
• The closely related LRRK1, not associated with PD, does not interact with microtubules.
• Specific amino acids in the LRRK2 GTPase domain were identified as mediating microtubule binding, and their mutation abolished this interaction without affecting kinase activity.

Conclusions:

• The study provides structural insights into how LRRK2 interacts with microtubules, a process influenced by PD mutations.
• The findings highlight differences between LRRK2 and LRRK1 regarding microtubule binding.
• The identified microtubule-binding residues offer potential targets for developing LRRK2-specific therapeutics for Parkinson's disease.